These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8807086

  • 1. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats.
    Chang M, Williams A, Ishizawa L, Knoppel A, van de Ven C, Cairo MS.
    Blood Cells Mol Dis; 1996; 22(1):57-67. PubMed ID: 8807086
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C, Fernandez GW, Herbst T, Knoppel A, Cairo MS.
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H.
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [Abstract] [Full Text] [Related]

  • 4. [The efficacy and mechanism of rhIL-11 in the management of chemotherapy-induced thrombocytopenia in acute leukemia].
    Cui XL, Wang L, Gao J, Qin P, Shi Y, Peng J, Hou M.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):345-7. PubMed ID: 16185478
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].
    Sun XF, Guan ZZ, Huang H, Zhou QH, Yi C, Zhang LJ, Zhu J, Li R, Zhou J, Zhang M, Guo Y.
    Ai Zheng; 2002 Aug; 21(8):892-5. PubMed ID: 12478901
    [Abstract] [Full Text] [Related]

  • 6. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
    Kaye JA.
    Stem Cells; 1996 Aug; 14 Suppl 1():256-60. PubMed ID: 11012229
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Li L, Xu CG, Wang XW, Guo QS, Sun YH, Sun LM.
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
    [Abstract] [Full Text] [Related]

  • 8. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):548-53. PubMed ID: 15144587
    [Abstract] [Full Text] [Related]

  • 9. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY, Feng FY, Song ST, Wang HQ, Zhang MH, Liu J, Liu XY, Xu LG, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2005 Jun 02; 27(6):373-6. PubMed ID: 16117903
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide and prostaglandin response to group B streptococcal infection in the lung.
    Natarajan G, Glibetic M, Raykova V, Ofenstein JP, Thomas RL, Aranda JV.
    Ann Clin Lab Sci; 2007 Jun 02; 37(2):170-6. PubMed ID: 17522374
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-dependent regulation of pro-inflammatory cytokines in group B streptococcal inflammation of rat lung.
    Raykova VD, Glibetic M, Ofenstein JP, Aranda JV.
    Ann Clin Lab Sci; 2003 Jun 02; 33(1):62-7. PubMed ID: 12661899
    [Abstract] [Full Text] [Related]

  • 12. Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
    Rinehart J, Margolin KA, Triozzi P, Hersh E, Campion M, Resta D, Levitt D.
    Clin Cancer Res; 1995 Oct 02; 1(10):1139-44. PubMed ID: 9815905
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic prophylaxis and non-group B streptococcal neonatal sepsis.
    Sutkin G, Krohn MA, Heine RP, Sweet RL.
    Obstet Gynecol; 2005 Mar 02; 105(3):581-6. PubMed ID: 15738028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liberal diagnosis and treatment of intrauterine infection reduces early-onset neonatal group B streptococcal infection but not sepsis by other pathogens.
    Wolf H, Schaap AH, Smit BJ, Spanjaard L, Adriaanse AH.
    Infect Dis Obstet Gynecol; 2000 Mar 02; 8(3-4):143-50. PubMed ID: 10968596
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.